Literature DB >> 22523155

Critical role of types 2 and 3 deiodinases in the negative regulation of gene expression by T₃in the mouse cerebral cortex.

Arturo Hernandez1, Beatriz Morte, Mónica M Belinchón, Ainhoa Ceballos, Juan Bernal.   

Abstract

Thyroid hormones regulate brain development and function through the control of gene expression, mediated by binding of T(3) to nuclear receptors. Brain T(3) concentration is tightly controlled by homeostatic mechanisms regulating transport and metabolism of T(4) and T(3). We have examined the role of the inactivating enzyme type 3 deiodinase (D3) in the regulation of 43 thyroid hormone-dependent genes in the cerebral cortex of 30-d-old mice. D3 inactivation increased slightly the expression of two of 22 positively regulated genes and significantly decreased the expression of seven of 21 negatively regulated genes. Administration of high doses of T(3) led to significant changes in the expression of 12 positive genes and three negative genes in wild-type mice. The response to T(3) treatment was enhanced in D3-deficient mice, both in the number of genes and in the amplitude of the response, demonstrating the role of D3 in modulating T(3) action. Comparison of the effects on gene expression observed in D3 deficiency with those in hypothyroidism, hyperthyroidism, and type 2 deiodinase (D2) deficiency revealed that the negative genes are more sensitive to D2 and D3 deficiencies than the positive genes. This observation indicates that, in normal physiological conditions, D2 and D3 play critical roles in maintaining local T(3) concentrations within a very narrow range. It also suggests that negatively and positively regulated genes do not have the same physiological significance or that their regulation by thyroid hormone obeys different paradigms at the molecular or cellular levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22523155      PMCID: PMC3359606          DOI: 10.1210/en.2011-1905

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  40 in total

1.  Type 3 iodothyronine deiodinase is selectively expressed in areas related to sexual differentiation in the newborn rat brain.

Authors:  M J Escámez; A Guadaño-Ferraz; A Cuadrado; J Bernal
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

2.  The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts.

Authors:  Arturo Hernandez; Steven Fiering; Elena Martinez; Valerie Anne Galton; Donald St Germain
Journal:  Endocrinology       Date:  2002-11       Impact factor: 4.736

Review 3.  Minireview: cracking the metabolic code for thyroid hormone signaling.

Authors:  Antonio C Bianco
Journal:  Endocrinology       Date:  2011-06-28       Impact factor: 4.736

4.  Depletion of L-3,5,3'-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone.

Authors:  H H Samuels; F Stanley; J Casanova
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

5.  Hepatic iodothyronine 5-deiodinase activity in Rana catesbeiana tadpoles at different stages of the life cycle.

Authors:  V A Galton; A Hiebert
Journal:  Endocrinology       Date:  1987-07       Impact factor: 4.736

Review 6.  Thyroid hormone receptors: multiple forms, multiple possibilities.

Authors:  M A Lazar
Journal:  Endocr Rev       Date:  1993-04       Impact factor: 19.871

7.  An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum.

Authors:  F R Crantz; J E Silva; P R Larsen
Journal:  Endocrinology       Date:  1982-02       Impact factor: 4.736

8.  Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism.

Authors:  Beatriz Morte; Jimena Manzano; Thomas Scanlan; Björn Vennström; Juan Bernal
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

9.  Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice.

Authors:  Paul M Yen; Xu Feng; Frederic Flamant; Yidong Chen; Robert L Walker; Roy E Weiss; Olivier Chassande; Jacques Samarut; Samuel Refetoff; Paul S Meltzer
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

10.  Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter.

Authors:  Edith C H Friesema; Sumita Ganguly; Amal Abdalla; Jocelyn E Manning Fox; Andrew P Halestrap; Theo J Visser
Journal:  J Biol Chem       Date:  2003-07-18       Impact factor: 5.157

View more
  35 in total

1.  Maternal L-thyroxine treatment during lactation affects learning and anxiety-like behaviors but not spatial memory in adult rat progeny.

Authors:  Burak Tan; Umut Bakkaloğlu; Meral Aşçıoğlu; Cem Süer
Journal:  Pharmacol Rep       Date:  2021-01-22       Impact factor: 3.024

2.  Do children with congenital hypothyroidism exhibit abnormal cortical morphology?

Authors:  Hayyah Clairman; Jovanka Skocic; Julieta E Lischinsky; Joanne Rovet
Journal:  Pediatr Res       Date:  2015-05-15       Impact factor: 3.756

Review 3.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

4.  Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes.

Authors:  Elizabeth A McAninch; Sungro Jo; Nailliw Z Preite; Erzsébet Farkas; Petra Mohácsik; Csaba Fekete; Péter Egri; Balázs Gereben; Yan Li; Youping Deng; Mary-Elizabeth Patti; Chantal Zevenbergen; Robin P Peeters; Deborah C Mash; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2015-01-08       Impact factor: 5.958

5.  Adult onset of type 3 deiodinase deficiency in mice alters brain gene expression and increases locomotor activity.

Authors:  J Patrizia Stohn; M Elena Martinez; Donald L St Germain; Arturo Hernandez
Journal:  Psychoneuroendocrinology       Date:  2019-09-18       Impact factor: 4.905

6.  Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency.

Authors:  Charles F Verge; Daniel Konrad; Michal Cohen; Caterina Di Cosmo; Alexandra M Dumitrescu; Teresa Marcinkowski; Shihab Hameed; Jill Hamilton; Roy E Weiss; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2012-09-19       Impact factor: 5.958

7.  Fetal Exposure to High Maternal Thyroid Hormone Levels Causes Central Resistance to Thyroid Hormone in Adult Humans and Mice.

Authors:  Panudda Srichomkwun; João Anselmo; Xiao-Hui Liao; G Sebastian Hönes; Lars C Moeller; Manuela Alonso-Sampedro; Roy E Weiss; Alexandra M Dumitrescu; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

Review 8.  Thyroid hormone and the brain: Mechanisms of action in development and role in protection and promotion of recovery after brain injury.

Authors:  Yan-Yun Liu; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2018-02-09       Impact factor: 12.310

Review 9.  Scope and limitations of iodothyronine deiodinases in hypothyroidism.

Authors:  Balázs Gereben; Elizabeth A McAninch; Miriam O Ribeiro; Antonio C Bianco
Journal:  Nat Rev Endocrinol       Date:  2015-09-29       Impact factor: 43.330

10.  Changes in thyroid status during perinatal development of MCT8-deficient male mice.

Authors:  Alfonso Massimiliano Ferrara; Xiao-Hui Liao; Pilar Gil-Ibáñez; Teresa Marcinkowski; Juan Bernal; Roy E Weiss; Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Endocrinology       Date:  2013-05-21       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.